Earnings Alerts

Talanx (TLX) Earnings: 2026 Net Income to Surpass Initial Targets with EU2.7B Forecast

By November 13, 2025 No Comments
  • Talanx anticipates 2026 net income to be approximately €2.7 billion.
  • This projection surpasses the initial estimate of €2.48 billion.
  • The Management Board initially projected a 30% increase in consolidated net income by 2027, reaching around €2.57 billion.
  • The updated projection suggests this target will be met and exceeded by 2026, a year earlier than planned.
  • Current analyst recommendations include 3 buy ratings, 2 hold ratings, and 3 sell ratings.

A look at Talanx Smart Scores

FactorScoreMagnitude
Value3
Dividend4
Growth5
Resilience4
Momentum4
OVERALL SMART SCORE4.0

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analyzing the Smartkarma Smart Scores for Talanx, the long-term outlook appears promising. With a solid score for growth and momentum, the company is positioned for future expansion and market drive. Additionally, strong scores in dividend and resilience indicate stability and potential returns for investors. The company’s diversified operations in insurance and financial services globally enhance its long-term value and resilience to market fluctuations.

Talanx, as a holding company with subsidiaries specializing in insurance and financial services, shows strength across key factors essential for long-term success. The combination of strong growth, resilience, and momentum bodes well for the company’s future performance and sustainability in the market. Investors seeking a company with a balanced focus on value, dividend returns, and growth potential may find Talanx to be an attractive long-term investment option.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars